ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 167 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98 | -100.0% | 100 | -98.7% | 0.00% | -100.0% |
| Q4 2019 | $470,000 | +62.6% | 7,876 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $289,000 | -23.3% | 7,876 | -2.9% | 0.00% | 0.0% |
| Q2 2019 | $377,000 | -66.0% | 8,111 | -70.6% | 0.00% | -75.0% |
| Q1 2019 | $1,108,000 | +206.9% | 27,604 | +251.7% | 0.00% | +300.0% |
| Q4 2018 | $361,000 | +7.4% | 7,849 | +3.8% | 0.00% | 0.0% |
| Q3 2018 | $336,000 | +60.8% | 7,562 | +42.0% | 0.00% | 0.0% |
| Q2 2018 | $209,000 | -81.3% | 5,326 | -65.5% | 0.00% | -80.0% |
| Q1 2018 | $1,116,000 | +255.4% | 15,436 | +223.2% | 0.01% | +400.0% |
| Q4 2017 | $314,000 | +119.6% | 4,776 | +54.1% | 0.00% | 0.0% |
| Q2 2017 | $143,000 | +31.2% | 3,100 | -6.1% | 0.00% | 0.0% |
| Q1 2017 | $109,000 | – | 3,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $33,967,000 | 11.67% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $20,644,000 | 0.58% |
| Bellevue Group AG | 4,519,164 | $54,455,000 | 0.55% |
| Rhenman & Partners Asset Management AB | 622,267 | $7,498,000 | 0.53% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 47,534 | $573,000 | 0.21% |
| WASATCH ADVISORS LP | 3,274,360 | $39,456,000 | 0.16% |
| EMC Capital Management | 27,566 | $246,000 | 0.14% |
| PDT Partners, LLC | 120,828 | $1,456,000 | 0.10% |
| Virtus ETF Advisers LLC | 17,773 | $214,000 | 0.09% |
| Pinz Capital Management, LP | 15,300 | $184,000 | 0.08% |